Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® in Combination with Cabometyx® as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma Biotech Investing
Jamieson Wellness Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Establishes 2021 Guidance Pharmaceutical Investing
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Pandion Therapeutics, Inc. Buyout Pharmaceutical Investing
PANDION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PAND and Encourages Investors to Contact the Firm Pharmaceutical Investing
Allergan, an AbbVie Company, Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia Biotech Investing
Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants Pharmaceutical Investing
HUMIRA® Receives FDA Approval to Treat Pediatric Patients Living with Moderately to Severely Active Ulcerative Colitis Biotech Investing
